Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Devices & Consumables > Demineralized Allograft Bone Substitute- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Demineralized Allograft Bone Substitute- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 108 Pages

Report ld: 3882529

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Demineralized Allograft Bone Substitute was estimated to be worth US$ 606 million in 2024 and is forecast to a readjusted size of US$ 949 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.

Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.

Demineralized Allograft Bone Substitute Market Size(US$)

M= millions and B=billions

The demineralized bone matrix market is primarily driven by the increasing demand for bone graft substitutes in orthopedic and dental surgeries. Demineralized bone matrix (DBM) is derived from human or animal bones and contains growth factors and proteins that promote bone regeneration and healing. The rising prevalence of musculoskeletal disorders, trauma, and dental conditions fuels the adoption of DBM as an effective and biocompatible bone graft material. However, the market also faces challenges, including the need for standardized and high-quality DBM products to ensure consistent clinical outcomes. Variability in DBM processing methods and composition may impact its efficacy and safety. Moreover, strict regulatory requirements and ethical concerns related to the sourcing and processing of DBM can pose challenges for manufacturers in the market.

This report aims to provide a comprehensive presentation of the global market for Demineralized Allograft Bone Substitute, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Demineralized Allograft Bone Substitute by region & country, by Type, and by Application.

The Demineralized Allograft Bone Substitute market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Demineralized Allograft Bone Substitute.

Market Segmentation

Report Metric
Details
Report Title
Demineralized Allograft Bone Substitute- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 949 million
CAGR(2025-2031)
6.7%
Market Size Available for Years
2025-2031
Global Demineralized Allograft Bone Substitute Companies Covered
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Global Demineralized Allograft Bone Substitute Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Demineralized Allograft Bone Substitute Market, Segment by Type
Gel
Putty
Putty with Chips
Others
Global Demineralized Allograft Bone Substitute Market, Segment by Application
Dental Surgery
Spine Surgery
Trauma Surgery
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Demineralized Allograft Bone Substitute manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Demineralized Allograft Bone Substitute in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Demineralized Allograft Bone Substitute in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Demineralized Allograft Bone Substitute Product Introduction
    1.2 Global Demineralized Allograft Bone Substitute Market Size Forecast
        1.2.1 Global Demineralized Allograft Bone Substitute Sales Value (2020-2031)
        1.2.2 Global Demineralized Allograft Bone Substitute Sales Volume (2020-2031)
        1.2.3 Global Demineralized Allograft Bone Substitute Sales Price (2020-2031)
    1.3 Demineralized Allograft Bone Substitute Market Trends & Drivers
        1.3.1 Demineralized Allograft Bone Substitute Industry Trends
        1.3.2 Demineralized Allograft Bone Substitute Market Drivers & Opportunity
        1.3.3 Demineralized Allograft Bone Substitute Market Challenges
        1.3.4 Demineralized Allograft Bone Substitute Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Demineralized Allograft Bone Substitute Players Revenue Ranking (2024)
    2.2 Global Demineralized Allograft Bone Substitute Revenue by Company (2020-2025)
    2.3 Global Demineralized Allograft Bone Substitute Players Sales Volume Ranking (2024)
    2.4 Global Demineralized Allograft Bone Substitute Sales Volume by Company Players (2020-2025)
    2.5 Global Demineralized Allograft Bone Substitute Average Price by Company (2020-2025)
    2.6 Key Manufacturers Demineralized Allograft Bone Substitute Manufacturing Base and Headquarters
    2.7 Key Manufacturers Demineralized Allograft Bone Substitute Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Demineralized Allograft Bone Substitute
    2.9 Demineralized Allograft Bone Substitute Market Competitive Analysis
        2.9.1 Demineralized Allograft Bone Substitute Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Demineralized Allograft Bone Substitute Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Demineralized Allograft Bone Substitute as of 2024)
    2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Gel
        3.1.2 Putty
        3.1.3 Putty with Chips
        3.1.4 Others
    3.2 Global Demineralized Allograft Bone Substitute Sales Value by Type
        3.2.1 Global Demineralized Allograft Bone Substitute Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Demineralized Allograft Bone Substitute Sales Value, by Type (2020-2031)
        3.2.3 Global Demineralized Allograft Bone Substitute Sales Value, by Type (%) (2020-2031)
    3.3 Global Demineralized Allograft Bone Substitute Sales Volume by Type
        3.3.1 Global Demineralized Allograft Bone Substitute Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Demineralized Allograft Bone Substitute Sales Volume, by Type (2020-2031)
        3.3.3 Global Demineralized Allograft Bone Substitute Sales Volume, by Type (%) (2020-2031)
    3.4 Global Demineralized Allograft Bone Substitute Average Price by Type (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Dental Surgery
        4.1.2 Spine Surgery
        4.1.3 Trauma Surgery
    4.2 Global Demineralized Allograft Bone Substitute Sales Value by Application
        4.2.1 Global Demineralized Allograft Bone Substitute Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Demineralized Allograft Bone Substitute Sales Value, by Application (2020-2031)
        4.2.3 Global Demineralized Allograft Bone Substitute Sales Value, by Application (%) (2020-2031)
    4.3 Global Demineralized Allograft Bone Substitute Sales Volume by Application
        4.3.1 Global Demineralized Allograft Bone Substitute Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Demineralized Allograft Bone Substitute Sales Volume, by Application (2020-2031)
        4.3.3 Global Demineralized Allograft Bone Substitute Sales Volume, by Application (%) (2020-2031)
    4.4 Global Demineralized Allograft Bone Substitute Average Price by Application (2020-2031)

5 Segmentation by Region
    5.1 Global Demineralized Allograft Bone Substitute Sales Value by Region
        5.1.1 Global Demineralized Allograft Bone Substitute Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Demineralized Allograft Bone Substitute Sales Value by Region (2020-2025)
        5.1.3 Global Demineralized Allograft Bone Substitute Sales Value by Region (2026-2031)
        5.1.4 Global Demineralized Allograft Bone Substitute Sales Value by Region (%), (2020-2031)
    5.2 Global Demineralized Allograft Bone Substitute Sales Volume by Region
        5.2.1 Global Demineralized Allograft Bone Substitute Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Demineralized Allograft Bone Substitute Sales Volume by Region (2020-2025)
        5.2.3 Global Demineralized Allograft Bone Substitute Sales Volume by Region (2026-2031)
        5.2.4 Global Demineralized Allograft Bone Substitute Sales Volume by Region (%), (2020-2031)
    5.3 Global Demineralized Allograft Bone Substitute Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        5.4.2 North America Demineralized Allograft Bone Substitute Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        5.5.2 Europe Demineralized Allograft Bone Substitute Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        5.6.2 Asia Pacific Demineralized Allograft Bone Substitute Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        5.7.2 South America Demineralized Allograft Bone Substitute Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        5.8.2 Middle East & Africa Demineralized Allograft Bone Substitute Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Demineralized Allograft Bone Substitute Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Demineralized Allograft Bone Substitute Sales Value
        6.2.1 Key Countries/Regions Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Demineralized Allograft Bone Substitute Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        6.3.2 United States Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Demineralized Allograft Bone Substitute Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        6.4.2 Europe Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Demineralized Allograft Bone Substitute Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        6.5.2 China Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Demineralized Allograft Bone Substitute Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        6.6.2 Japan Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Demineralized Allograft Bone Substitute Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        6.7.2 South Korea Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Demineralized Allograft Bone Substitute Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        6.8.2 Southeast Asia Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Demineralized Allograft Bone Substitute Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Demineralized Allograft Bone Substitute Sales Value, 2020-2031
        6.9.2 India Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Demineralized Allograft Bone Substitute Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 Medtronic
        7.1.1 Medtronic Company Information
        7.1.2 Medtronic Introduction and Business Overview
        7.1.3 Medtronic Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Medtronic Demineralized Allograft Bone Substitute Product Offerings
        7.1.5 Medtronic Recent Development
    7.2 J &J (DePuy Synthes)
        7.2.1 J &J (DePuy Synthes) Company Information
        7.2.2 J &J (DePuy Synthes) Introduction and Business Overview
        7.2.3 J &J (DePuy Synthes) Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 J &J (DePuy Synthes) Demineralized Allograft Bone Substitute Product Offerings
        7.2.5 J &J (DePuy Synthes) Recent Development
    7.3 SeaSpine
        7.3.1 SeaSpine Company Information
        7.3.2 SeaSpine Introduction and Business Overview
        7.3.3 SeaSpine Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 SeaSpine Demineralized Allograft Bone Substitute Product Offerings
        7.3.5 SeaSpine Recent Development
    7.4 Xtant Medical
        7.4.1 Xtant Medical Company Information
        7.4.2 Xtant Medical Introduction and Business Overview
        7.4.3 Xtant Medical Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Xtant Medical Demineralized Allograft Bone Substitute Product Offerings
        7.4.5 Xtant Medical Recent Development
    7.5 Zimmer Biomet
        7.5.1 Zimmer Biomet Company Information
        7.5.2 Zimmer Biomet Introduction and Business Overview
        7.5.3 Zimmer Biomet Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Zimmer Biomet Demineralized Allograft Bone Substitute Product Offerings
        7.5.5 Zimmer Biomet Recent Development
    7.6 Stryker
        7.6.1 Stryker Company Information
        7.6.2 Stryker Introduction and Business Overview
        7.6.3 Stryker Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 Stryker Demineralized Allograft Bone Substitute Product Offerings
        7.6.5 Stryker Recent Development
    7.7 Straumann
        7.7.1 Straumann Company Information
        7.7.2 Straumann Introduction and Business Overview
        7.7.3 Straumann Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Straumann Demineralized Allograft Bone Substitute Product Offerings
        7.7.5 Straumann Recent Development
    7.8 Wright Medical Group
        7.8.1 Wright Medical Group Company Information
        7.8.2 Wright Medical Group Introduction and Business Overview
        7.8.3 Wright Medical Group Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.8.4 Wright Medical Group Demineralized Allograft Bone Substitute Product Offerings
        7.8.5 Wright Medical Group Recent Development
    7.9 Hans Biomed
        7.9.1 Hans Biomed Company Information
        7.9.2 Hans Biomed Introduction and Business Overview
        7.9.3 Hans Biomed Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.9.4 Hans Biomed Demineralized Allograft Bone Substitute Product Offerings
        7.9.5 Hans Biomed Recent Development
    7.10 Arthrex
        7.10.1 Arthrex Company Information
        7.10.2 Arthrex Introduction and Business Overview
        7.10.3 Arthrex Demineralized Allograft Bone Substitute Sales, Revenue, Price and Gross Margin (2020-2025)
        7.10.4 Arthrex Demineralized Allograft Bone Substitute Product Offerings
        7.10.5 Arthrex Recent Development

8 Industry Chain Analysis
    8.1 Demineralized Allograft Bone Substitute Industrial Chain
    8.2 Demineralized Allograft Bone Substitute Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Demineralized Allograft Bone Substitute Sales Model
        8.5.2 Sales Channel
        8.5.3 Demineralized Allograft Bone Substitute Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Demineralized Allograft Bone Substitute Market Trends
 Table 2. Demineralized Allograft Bone Substitute Market Drivers & Opportunity
 Table 3. Demineralized Allograft Bone Substitute Market Challenges
 Table 4. Demineralized Allograft Bone Substitute Market Restraints
 Table 5. Global Demineralized Allograft Bone Substitute Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Demineralized Allograft Bone Substitute Revenue Market Share by Company (2020-2025)
 Table 7. Global Demineralized Allograft Bone Substitute Sales Volume by Company (2020-2025) & (K Units)
 Table 8. Global Demineralized Allograft Bone Substitute Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Demineralized Allograft Bone Substitute Price by Company (2020-2025) & (US$/Unit)
 Table 10. Key Manufacturers Demineralized Allograft Bone Substitute Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Demineralized Allograft Bone Substitute Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Demineralized Allograft Bone Substitute
 Table 13. Global Demineralized Allograft Bone Substitute Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Demineralized Allograft Bone Substitute as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Demineralized Allograft Bone Substitute Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Demineralized Allograft Bone Substitute Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Demineralized Allograft Bone Substitute Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Demineralized Allograft Bone Substitute Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Demineralized Allograft Bone Substitute Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Demineralized Allograft Bone Substitute Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global Demineralized Allograft Bone Substitute Sales Volume by Type (2020-2025) & (K Units)
 Table 23. Global Demineralized Allograft Bone Substitute Sales Volume by Type (2026-2031) & (K Units)
 Table 24. Global Demineralized Allograft Bone Substitute Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Demineralized Allograft Bone Substitute Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Demineralized Allograft Bone Substitute Price by Type (2020-2025) & (US$/Unit)
 Table 27. Global Demineralized Allograft Bone Substitute Price by Type (2026-2031) & (US$/Unit)
 Table 28. Global Demineralized Allograft Bone Substitute Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Demineralized Allograft Bone Substitute Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Demineralized Allograft Bone Substitute Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Demineralized Allograft Bone Substitute Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Demineralized Allograft Bone Substitute Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Demineralized Allograft Bone Substitute Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
 Table 34. Global Demineralized Allograft Bone Substitute Sales Volume by Application (2020-2025) & (K Units)
 Table 35. Global Demineralized Allograft Bone Substitute Sales Volume by Application (2026-2031) & (K Units)
 Table 36. Global Demineralized Allograft Bone Substitute Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Demineralized Allograft Bone Substitute Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Demineralized Allograft Bone Substitute Price by Application (2020-2025) & (US$/Unit)
 Table 39. Global Demineralized Allograft Bone Substitute Price by Application (2026-2031) & (US$/Unit)
 Table 40. Global Demineralized Allograft Bone Substitute Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Demineralized Allograft Bone Substitute Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Demineralized Allograft Bone Substitute Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Demineralized Allograft Bone Substitute Sales Value by Region (2020-2025) & (%)
 Table 44. Global Demineralized Allograft Bone Substitute Sales Value by Region (2026-2031) & (%)
 Table 45. Global Demineralized Allograft Bone Substitute Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
 Table 46. Global Demineralized Allograft Bone Substitute Sales Volume by Region (2020-2025) & (K Units)
 Table 47. Global Demineralized Allograft Bone Substitute Sales Volume by Region (2026-2031) & (K Units)
 Table 48. Global Demineralized Allograft Bone Substitute Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Demineralized Allograft Bone Substitute Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Demineralized Allograft Bone Substitute Average Price by Region (2020-2025) & (US$/Unit)
 Table 51. Global Demineralized Allograft Bone Substitute Average Price by Region (2026-2031) & (US$/Unit)
 Table 52. Key Countries/Regions Demineralized Allograft Bone Substitute Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Demineralized Allograft Bone Substitute Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Demineralized Allograft Bone Substitute Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Demineralized Allograft Bone Substitute Sales Volume, (2020-2025) & (K Units)
 Table 56. Key Countries/Regions Demineralized Allograft Bone Substitute Sales Volume, (2026-2031) & (K Units)
 Table 57. Medtronic Company Information
 Table 58. Medtronic Introduction and Business Overview
 Table 59. Medtronic Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 60. Medtronic Demineralized Allograft Bone Substitute Product Offerings
 Table 61. Medtronic Recent Development
 Table 62. J &J (DePuy Synthes) Company Information
 Table 63. J &J (DePuy Synthes) Introduction and Business Overview
 Table 64. J &J (DePuy Synthes) Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 65. J &J (DePuy Synthes) Demineralized Allograft Bone Substitute Product Offerings
 Table 66. J &J (DePuy Synthes) Recent Development
 Table 67. SeaSpine Company Information
 Table 68. SeaSpine Introduction and Business Overview
 Table 69. SeaSpine Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 70. SeaSpine Demineralized Allograft Bone Substitute Product Offerings
 Table 71. SeaSpine Recent Development
 Table 72. Xtant Medical Company Information
 Table 73. Xtant Medical Introduction and Business Overview
 Table 74. Xtant Medical Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Xtant Medical Demineralized Allograft Bone Substitute Product Offerings
 Table 76. Xtant Medical Recent Development
 Table 77. Zimmer Biomet Company Information
 Table 78. Zimmer Biomet Introduction and Business Overview
 Table 79. Zimmer Biomet Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Zimmer Biomet Demineralized Allograft Bone Substitute Product Offerings
 Table 81. Zimmer Biomet Recent Development
 Table 82. Stryker Company Information
 Table 83. Stryker Introduction and Business Overview
 Table 84. Stryker Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Stryker Demineralized Allograft Bone Substitute Product Offerings
 Table 86. Stryker Recent Development
 Table 87. Straumann Company Information
 Table 88. Straumann Introduction and Business Overview
 Table 89. Straumann Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Straumann Demineralized Allograft Bone Substitute Product Offerings
 Table 91. Straumann Recent Development
 Table 92. Wright Medical Group Company Information
 Table 93. Wright Medical Group Introduction and Business Overview
 Table 94. Wright Medical Group Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Wright Medical Group Demineralized Allograft Bone Substitute Product Offerings
 Table 96. Wright Medical Group Recent Development
 Table 97. Hans Biomed Company Information
 Table 98. Hans Biomed Introduction and Business Overview
 Table 99. Hans Biomed Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Hans Biomed Demineralized Allograft Bone Substitute Product Offerings
 Table 101. Hans Biomed Recent Development
 Table 102. Arthrex Company Information
 Table 103. Arthrex Introduction and Business Overview
 Table 104. Arthrex Demineralized Allograft Bone Substitute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Arthrex Demineralized Allograft Bone Substitute Product Offerings
 Table 106. Arthrex Recent Development
 Table 107. Key Raw Materials Lists
 Table 108. Raw Materials Key Suppliers Lists
 Table 109. Demineralized Allograft Bone Substitute Downstream Customers
 Table 110. Demineralized Allograft Bone Substitute Distributors List
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources


List of Figures
 Figure 1. Demineralized Allograft Bone Substitute Product Picture
 Figure 2. Global Demineralized Allograft Bone Substitute Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Demineralized Allograft Bone Substitute Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Demineralized Allograft Bone Substitute Sales Volume (2020-2031) & (K Units)
 Figure 5. Global Demineralized Allograft Bone Substitute Sales Price (2020-2031) & (US$/Unit)
 Figure 6. Demineralized Allograft Bone Substitute Report Years Considered
 Figure 7. Global Demineralized Allograft Bone Substitute Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Demineralized Allograft Bone Substitute Players Sales Volume Ranking (2024) & (K Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Demineralized Allograft Bone Substitute Revenue in 2024
 Figure 10. Demineralized Allograft Bone Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Gel Picture
 Figure 12. Putty Picture
 Figure 13. Putty with Chips Picture
 Figure 14. Others Picture
 Figure 15. Global Demineralized Allograft Bone Substitute Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 16. Global Demineralized Allograft Bone Substitute Sales Value Market Share by Type, 2024 & 2031
 Figure 17. Global Demineralized Allograft Bone Substitute Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
 Figure 18. Global Demineralized Allograft Bone Substitute Sales Volume Market Share by Type, 2024 & 2031
 Figure 19. Global Demineralized Allograft Bone Substitute Price by Type (2020-2031) & (US$/Unit)
 Figure 20. Product Picture of Dental Surgery
 Figure 21. Product Picture of Spine Surgery
 Figure 22. Product Picture of Trauma Surgery
 Figure 23. Global Demineralized Allograft Bone Substitute Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 24. Global Demineralized Allograft Bone Substitute Sales Value Market Share by Application, 2024 & 2031
 Figure 25. Global Demineralized Allograft Bone Substitute Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
 Figure 26. Global Demineralized Allograft Bone Substitute Sales Volume Market Share by Application, 2024 & 2031
 Figure 27. Global Demineralized Allograft Bone Substitute Price by Application (2020-2031) & (US$/Unit)
 Figure 28. North America Demineralized Allograft Bone Substitute Sales Value (2020-2031) & (US$ Million)
 Figure 29. North America Demineralized Allograft Bone Substitute Sales Value by Country (%), 2024 VS 2031
 Figure 30. Europe Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Europe Demineralized Allograft Bone Substitute Sales Value by Country (%), 2024 VS 2031
 Figure 32. Asia Pacific Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Demineralized Allograft Bone Substitute Sales Value by Region (%), 2024 VS 2031
 Figure 34. South America Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 35. South America Demineralized Allograft Bone Substitute Sales Value by Country (%), 2024 VS 2031
 Figure 36. Middle East & Africa Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 37. Middle East & Africa Demineralized Allograft Bone Substitute Sales Value by Country (%), 2024 VS 2031
 Figure 38. Key Countries/Regions Demineralized Allograft Bone Substitute Sales Value (%), (2020-2031)
 Figure 39. Key Countries/Regions Demineralized Allograft Bone Substitute Sales Volume (%), (2020-2031)
 Figure 40. United States Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 41. United States Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
 Figure 42. United States Demineralized Allograft Bone Substitute Sales Value by Application (%), 2024 VS 2031
 Figure 43. Europe Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Europe Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
 Figure 45. Europe Demineralized Allograft Bone Substitute Sales Value by Application (%), 2024 VS 2031
 Figure 46. China Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 47. China Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
 Figure 48. China Demineralized Allograft Bone Substitute Sales Value by Application (%), 2024 VS 2031
 Figure 49. Japan Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Japan Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
 Figure 51. Japan Demineralized Allograft Bone Substitute Sales Value by Application (%), 2024 VS 2031
 Figure 52. South Korea Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 53. South Korea Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
 Figure 54. South Korea Demineralized Allograft Bone Substitute Sales Value by Application (%), 2024 VS 2031
 Figure 55. Southeast Asia Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 56. Southeast Asia Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
 Figure 57. Southeast Asia Demineralized Allograft Bone Substitute Sales Value by Application (%), 2024 VS 2031
 Figure 58. India Demineralized Allograft Bone Substitute Sales Value, (2020-2031) & (US$ Million)
 Figure 59. India Demineralized Allograft Bone Substitute Sales Value by Type (%), 2024 VS 2031
 Figure 60. India Demineralized Allograft Bone Substitute Sales Value by Application (%), 2024 VS 2031
 Figure 61. Demineralized Allograft Bone Substitute Industrial Chain
 Figure 62. Demineralized Allograft Bone Substitute Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed

Description

The global market for Demineralized Allograft Bone Substitute was estimated to be worth US$ 606 million in 2024 and is forecast to a readjusted size of US$ 949 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.

Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.

Market Segmentation

Related Reports

Global Demineralized Allograft Bone Substitute Market Research Report 2024
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
Published: 2024-02-21
Pages: 89
USD 2900.00
(Single User License)
Global Demineralized Allograft Bone Substitute Market Insights, Forecast to 2030
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
Published: 2024-04-10
Pages: 107
USD 4900.00
(Single User License)
Demineralized Allograft Bone Substitute - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
Published: 2024-01-09
Pages: 127
USD 3950.00
(Single User License)
Global Demineralized Allograft Bone Substitute Market Research Report 2025
The global market for Demineralized Allograft Bone Substitute was valued at US$ 606 million in the year 2024 and is projected to reach a revised size of US$ 949 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-02-14
Pages: 79
USD 2900.00
(Single User License)
Global Demineralized Allograft Bone Substitute Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Demineralized Allograft Bone Substitute market size was US$ 606 million in 2024 and is forecast to a readjusted size of US$ 949 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 79
USD 4250.00
(Single User License)
Global Demineralized Allograft Bone Substitute Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Demineralized Allograft Bone Substitute market is projected to grow from US$ 606 million in 2024 to US$ 949 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 131
USD 4900.00
(Single User License)
Global Demineralized Allograft Bone Substitute Market Research Report 2026
The global Demineralized Allograft Bone Substitute market was valued at US$ 643 million in 2025 and is anticipated to reach US$ 1006 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-02-11
Pages: 108
USD 2900.00
(Single User License)
Demineralized Allograft Bone Substitute- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Demineralized Allograft Bone Substitute was estimated to be worth US$ 643 million in 2025 and is projected to reach US$ 1006 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-02-11
Pages: 109
USD 3950.00
(Single User License)

Global Demineralized Allograft Bone Substitute Market Research Report 2024
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
Published: 2024-02-21
Pages: 89
USD 2900.00 ()
Global Demineralized Allograft Bone Substitute Market Insights, Forecast to 2030
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
Published: 2024-04-10
Pages: 107
USD 4900.00 ()
Demineralized Allograft Bone Substitute - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
Published: 2024-01-09
Pages: 127
USD 3950.00 ()
Global Demineralized Allograft Bone Substitute Market Research Report 2025
The global market for Demineralized Allograft Bone Substitute was valued at US$ 606 million in the year 2024 and is projected to reach a revised size of US$ 949 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-02-14
Pages: 79
USD 2900.00 ()
Global Demineralized Allograft Bone Substitute Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Demineralized Allograft Bone Substitute market size was US$ 606 million in 2024 and is forecast to a readjusted size of US$ 949 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 79
USD 4250.00 ()
Global Demineralized Allograft Bone Substitute Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Demineralized Allograft Bone Substitute market is projected to grow from US$ 606 million in 2024 to US$ 949 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 131
USD 4900.00 ()
Global Demineralized Allograft Bone Substitute Market Research Report 2026
The global Demineralized Allograft Bone Substitute market was valued at US$ 643 million in 2025 and is anticipated to reach US$ 1006 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-02-11
Pages: 108
USD 2900.00 ()
Demineralized Allograft Bone Substitute- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Demineralized Allograft Bone Substitute was estimated to be worth US$ 643 million in 2025 and is projected to reach US$ 1006 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-02-11
Pages: 109
USD 3950.00 ()